Helio Silva Sader (H S Sader, Helio S Sader)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Venues

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Open forum infectious diseases

The Journal of antimicrobial chemotherapy

JMI Laboratories

This page only lists publications with an associated author ORCID identifier.

Affiliation History

JMI Laboratories

United States

Senior Director for Microbiology and Surveillance

Federal University of Sao Paulo

Brazil

Associate Professor :: Division of Infectious Diseases

Publications

Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy 68 (5) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy 68 (5) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy 68 (5) (2024)
Helio Silva Sader, Rodrigo E Mendes, John H Kimbrough, Cory M Hubler, Mariana Castanheira
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Helio Silva Sader, Rodrigo E Mendes, John H Kimbrough, Cory M Hubler, Mariana Castanheira
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy (2024)
Susanne Paukner, Rodrigo Elisandro Mendes, S J Ryan Arends, Gisela Gassner, Steven P Gelone, Helio Silva Sader
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Susanne Paukner, Rodrigo Elisandro Mendes, S J Ryan Arends, Gisela Gassner, Steven P Gelone, Helio Silva Sader
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Susanne Paukner, Rodrigo Elisandro Mendes, S J Ryan Arends, Gisela Gassner, Steven P Gelone, Helio Silva Sader
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms. The Journal of antimicrobial chemotherapy (2023)
Helio Silva Sader, Cecilia G Carvalhaes, Michael D Huband, Rodrigo E Mendes, Mariana Castanheira
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (4) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, John H Kimbrough, Valerie Kantro, Mariana Castanheira
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers. Open forum infectious diseases 10 (2) (2023)
Helio Silva Sader, Mariana Castanheira, John H Kimbrough, Valerie Kantro, Rodrigo Elisandro Mendes
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21). JAC-antimicrobial resistance 5 (2) (2023)
A J Lepak, Michael Trang, J P Hammel, Helio Silva Sader, Sujata M Bhavnani, Brian D VanScoy, J M Pogue, Paul G Ambrose, David R Andes, null null
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial agents and chemotherapy (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, Cecilia Godoy Carvalhaes, John H Kimbrough, Mariana Castanheira
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021). Open forum infectious diseases 10 (2) (2023)
Helio Silva Sader, Cecilia G Carvalhaes, Michael D Huband, Rodrigo E Mendes, Mariana Castanheira
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (4) (2023)
Helio Silva Sader, Cecilia G Carvalhaes, Michael D Huband, Rodrigo E Mendes, Mariana Castanheira
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (4) (2023)
Michael D Huband, Kelley A Fedler, Helio Silva Sader, Gregory G Stone, Mariana Castanheira
Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination. Journal of clinical microbiology (2023)
Helio Silva Sader, Cecilia G Carvalhaes, Michael D Huband, Rodrigo E Mendes, Mariana Castanheira
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Helio Silva Sader, Mariana Castanheira, John H Kimbrough, Valerie Kantro, Rodrigo Elisandro Mendes
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21). JAC-antimicrobial resistance 5 (2) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, John H Kimbrough, Valerie Kantro, Mariana Castanheira
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers. Open forum infectious diseases 10 (2) (2023)
Mariana Castanheira, John H Kimbrough, Sean DeVries, Rodrigo Elisandro Mendes, Helio Silva Sader
Trends of β-Lactamase Occurrence Among Escherichia coli and Klebsiella pneumoniae in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type. Open forum infectious diseases 10 (2) (2023)
Michael A Pfaller, Rodrigo Elisandro Mendes, Helio Silva Sader, Mariana Castanheira, Cecilia Godoy Carvalhaes
Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019). Journal of chemotherapy (Florence, Italy) (2023)
Helio Silva Sader, Cecilia G Carvalhaes, Michael D Huband, Rodrigo E Mendes, Mariana Castanheira
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (4) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, Cecilia Godoy Carvalhaes, John H Kimbrough, Mariana Castanheira
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021). Open forum infectious diseases 10 (2) (2023)
Helio Silva Sader, Cecilia G Carvalhaes, Michael D Huband, Rodrigo E Mendes, Mariana Castanheira
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 42 (4) (2023)
Mariana Castanheira, John H Kimbrough, Sean DeVries, Rodrigo Elisandro Mendes, Helio Silva Sader
Trends of β-Lactamase Occurrence Among Escherichia coli and Klebsiella pneumoniae in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type. Open forum infectious diseases 10 (2) (2023)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Jennifer M Streit, Rodrigo E Mendes
Five-year analysis of the in vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programme. JAC-antimicrobial resistance 4 (5) (2022)
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo Elisandro Mendes, Timothy B Doyle, Helio Silva Sader
Prevalence of carbapenemase genes among carbapenem-nonsusceptible Enterobacterales collected in US hospitals in a five-year period and activity of ceftazidime/avibactam and comparator agents. JAC-antimicrobial resistance 4 (5) (2022)
Helio Silva Sader, Rodrigo Elisandro Mendes, S J Ryan Arends, Cecilia Godoy Carvalhaes, Mariana Castanheira
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (3) (2022)
Helio Silva Sader, Rodrigo E Mendes, Leonard R Duncan, Cecilia Godoy Carvalhaes, Mariana Castanheira
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19). The Journal of antimicrobial chemotherapy 77 (10) (2022)
Helio Silva Sader, Mariana Castanheira, Michael D Huband, Dee Shortridge, Cecilia Godoy Carvalhaes, Rodrigo Elisandro Mendes
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (5) (2022)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Paul Richard Rhomberg, Mariana Castanheira, Sean DeVries, Rodrigo Elisandro Mendes
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019). The Pediatric infectious disease journal 41 (9) (2022)
Leonard R Duncan, Wen Wang, Helio Silva Sader
In Vitro Potency and Spectrum of the Novel Polymyxin MRX-8 Tested against Clinical Isolates of Gram-Negative Bacteria. Antimicrobial agents and chemotherapy 66 (5) (2022)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Jennifer M Streit, Mariana Castanheira, Rodrigo Elisandro Mendes
Activity of Oritavancin Against Gram-positive Pathogens Causing Bloodstream Infections in the United States Over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019). Antimicrobial agents and chemotherapy (2021)
Cecilia G Carvalhaes, Leonard R Duncan, Wen Wang, Helio Silva Sader
In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe. Antimicrobial agents and chemotherapy 64 (11) (2020)
Helio Silva Sader, Leonard R Duncan, S J Ryan Arends, Cecilia G Carvalhaes, Mariana Castanheira
Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide. Antimicrobial agents and chemotherapy 64 (11) (2020)

Helio Silva Sader.css-eqlu8i{font-size:small;padding-left:4px;} (H S Sader, Helio S Sader)

Publication Activity (10 Years)

Top Topics

Top Venues

Helio Silva Sader (H S Sader, Helio S Sader)